erythromycin has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, R; Eftychis, HE; Fernandes, AC | 1 |
| Akagawa, KS; Keicho, N; Kudoh, S; Yotsumoto, H | 1 |
2 other study(ies) available for erythromycin and concanavalin a
| Article | Year |
|---|---|
Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes.
Topics: Adjuvants, Immunologic; Adult; Concanavalin A; Dinoprostone; Erythromycin; Humans; In Vitro Techniques; Kinetics; Leukocytes; Lymphocyte Activation; Monocytes; Neutrophils; Phytohemagglutinins; Prostaglandins E | 1984 |
Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
Topics: Antigens; Cell Line; Concanavalin A; Cyclosporine; Drug Synergism; Erythromycin; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Motilin; Receptors, Interleukin-2; Tacrolimus; Tumor Cells, Cultured | 1993 |